Inhibitory effect of MyoD on the proliferation of breast cancer cells

Skeletal muscle is rich in lymphatic vessels, with an abundant blood supply, and it is an infrequent site of cancer metastasis. Previous studies have demonstrated that enhanced secretion of MyoD may occur when skeletal muscle is injured or becomes cancerous. It was hypothesized that MyoD may act as an endogenous cytokine to inhibit the proliferation of cancer cells. To verify the possible effect of this protein on tumor cell proliferation, C2C12 mouse skeletal muscle cells and 4T1 mouse breast cancer cells were co-cultured using embedded Transwell plates. Following co-culture, cell cycle analysis revealed that C2C12 muscle cells were able to inhibit the proliferation of the breast cancer cells. Subsequently, MyoD was silenced in C2C12 cells to assess its effect on 4T1 cell proliferation. Following co-culture with MyoD-silenced cells, a 5-ethynyl-20-deoxyuridine assay indicated that MyoD silencing prevented the reduction in proliferation of 4T1 cells induced by untransfected C2C12 cells. In summary, the results indicated that MyoD inhibits the proliferation of breast cancer cells and may be a tumor suppressor factor.

[1]  A. Surov,et al.  Skelettmuskelmetastasen , 2018, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[2]  J. Drouin,et al.  Redox Regulation by Pitx2 and Pitx3 Is Critical for Fetal Myogenesis. , 2016, Developmental cell.

[3]  N. Fujita,et al.  Effect of heat stress soon after muscle injury on the expression of MyoD and myogenin during regeneration process. , 2014, Journal of musculoskeletal & neuronal interactions.

[4]  C. Battistelli,et al.  Functional interplay between MyoD and CTCF in regulating long-range chromatin interactions during differentiation , 2014, Journal of Cell Science.

[5]  B. Berks,et al.  Structural biology of Tat protein transport. , 2014, Current opinion in structural biology.

[6]  M. Ewen,et al.  Retinoblastoma Protein and MyoD Function Together to Effect the Repression of Fra-1 and in Turn Cyclin D1 during Terminal Cell Cycle Arrest Associated with Myogenesis* , 2014, The Journal of Biological Chemistry.

[7]  M. Kirschner,et al.  Molecular ties between the cell cycle and differentiation in embryonic stem cells , 2014, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Pena,et al.  Application of the microarray technology to the transcriptional analysis of muscle phenotypes in pigs. , 2014, Animal genetics.

[9]  T. Guise,et al.  Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness , 2014, Clinical Cancer Research.

[10]  Yun-Jaie Choi,et al.  Heat-shock protein beta 1 regulates androgen-mediated bovine myogenesis , 2014, Biotechnology Letters.

[11]  K. Jensen,et al.  Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III. , 2014, Cancer research.

[12]  C. Fletcher,et al.  Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma , 2014, The Journal of pathology.

[13]  A. Iavarone,et al.  The ID proteins: master regulators of cancer stem cells and tumour aggressiveness , 2014, Nature Reviews Cancer.

[14]  E. Clementi,et al.  Nitric oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors. , 2014, Experimental cell research.

[15]  F. Mendoza,et al.  Cancer Stem Cells in Brain Tumors , 2014 .

[16]  R. Sen,et al.  Metastatic Carcinoma in Skeletal Muscle - A Rare Presentation. , 2014 .

[17]  L. Aparicio,et al.  Stem Cells in Cancer: Should We Believe or Not? , 2014, Springer Netherlands.

[18]  S. Attia,et al.  Diffuse skeletal muscle metastases from sacral chordoma , 2014, Skeletal Radiology.

[19]  J. Olson,et al.  MyoD is a tumor suppressor gene in medulloblastoma. , 2013, Cancer research.

[20]  R. Kumar,et al.  Skeletal muscle metastases: a three-part study of a not-so-rare entity , 2012, Skeletal Radiology.

[21]  E. Karaoz,et al.  Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems. , 2011, Cytotherapy.

[22]  S. Kuo,et al.  Affinity of synthetic peptide fragments of MyoD for Id1 protein and their biological effects in several cancer cells , 2010, Journal of peptide science : an official publication of the European Peptide Society.

[23]  K. Tsuchida,et al.  Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle , 2010, Nature Cell Biology.

[24]  H. Hirai,et al.  Structure and functions of powerful transactivators: VP16, MyoD and FoxA. , 2010, The International journal of developmental biology.

[25]  A. Harel-Bellan,et al.  Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. , 2007, Genes & development.

[26]  Atsushi Asakura,et al.  MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions , 2005, The Journal of cell biology.

[27]  V. Uversky,et al.  Structure and function of α-fetoprotein: a biophysical overview , 2000 .

[28]  V. Uversky,et al.  Structure and function of alpha-fetoprotein: a biophysical overview. , 2000, Biochimica et biophysica acta.

[29]  W. Gerald,et al.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.

[30]  S. Tapscott,et al.  The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. , 1995, Developmental biology.

[31]  Robert K. Davis,et al.  The myoD gene family: nodal point during specification of the muscle cell lineage. , 1991, Science.

[32]  R. Pepperkok,et al.  Cell proliferation inhibited by MyoD1 independently of myogenic differentiation , 1990, Nature.

[33]  L. Herrera.  Skeletal muscle metastases , 1988, Diseases of the colon and rectum.